Diabetes drug may shield leg artery patients from heart attacks and amputations
NCT ID NCT07157475
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study is looking at whether a class of diabetes drugs called SGLT-2 inhibitors (or "flozins") can reduce the risk of serious heart problems and limb complications in people who have had surgery to open blocked leg arteries. Researchers will compare the outcomes of 300 patients who took these drugs after their procedure with those who did not. The goal is to see if the drug helps prevent heart attacks, strokes, repeat surgeries, or amputations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE(PAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wroclaw Medical University
RECRUITINGWroclaw, Lower Silesian Voivodeship, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.